Validation pour Ingenuity226

vers la météo de la validation par utilisateur

Ingenuity226

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 18 - PMID ?

In female adult SP missing a ovary , subcutaneous injection of NODE protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 1

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 2

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 3

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 4

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 5

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 6

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 7

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 8

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 9

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 10

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 11

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 12

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 13

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 14

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 15

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                                                                                                       
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 16

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 17

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 18

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 19

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 20

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 21

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 22

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 23

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |                                      +----------------------------------------------SUBJ:V-N---------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |                                      |                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+                                      +----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,injection)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 24

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 25

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 26

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 27

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 28

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 29

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |      +--------------------------------------------------------------SUBJ:V-N-------------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |      |                                                             +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+      |        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,miss)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 30

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 31

                    +---------------------------------------------------------------COMP:V-N(In)---------------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                    |               +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
                    |               |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,__SP__)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 32

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 33

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 34

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 35

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 36

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 37

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 38

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 39

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 40

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 41

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 42

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 43

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 44

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 45

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 46

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 47

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 48

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 49

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 50

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 51

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 52

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 53

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 54

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 55

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 56

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 57

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 58

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 59

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 60

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 61

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 62

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 63

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 64

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 65

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 66

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 67

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 68

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 69

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 70

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 71

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
                    |                                                                    |                       +------------COMP:N-N(of)------------+                                                              +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 72

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 73

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 74

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 75

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 76

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 77

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 78

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 79

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 80

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 81

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 82

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 83

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 84

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 85

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 86

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 87

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 88

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 89

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 90

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 91

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 92

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 93

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 94

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 95

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 96

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 97

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 98

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 99

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 100

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 101

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 102

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 103

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+-----------------APPOS----------------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+SUBJ:V+-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
APPOS (__SP__,injection)
SUBJ:V-N (miss,__SP__)
OBJ:V-N (miss,ovary)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 104

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 105

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 106

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 107

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 108

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 109

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          |                                                 
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+-----------------OBJ:V-N----------------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |                       +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |                       |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 110

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +-MOD_ATT:N-N+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 111

                    +------------------------------------------------------------------------------------------COMP:V-N(In)------------------------------------------------------------------------------------------+                                                 
                    |                                                                    +---------------------OBJ:V-N--------------------+                                                                          +-----------------OBJ:V-N----------------+        
       +MOD_ATT:N-AD+               +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-----MOD_ATT:N-N-----+------------SUBJ:V-N-----------+        +----------MOD_ATT:N-N----------+        
       |     +MOD_AT+      +-OBJ:V-N+           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+------COMP:N-N(of)------+      |        |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |                        |      |        |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-ADJ (__SP__,female)
MOD_ATT:N-N (__SP__,adult)
OBJ:V-N (miss,ovary)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
MOD_ATT:N-N (growth,increase)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,that)
COMP:V-N(In) (involve,__SP__)
SUBJ:V-N (involve,growth)
OBJ:V-N (involve,bisphosphonate)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 112

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                       
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 113

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                                                                                                       
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    |                       +------------COMP:N-N(of)------------+        |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (mcg/kg/day,day)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 114

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)

Analyse 115

                           +------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------+                     +------------------------------COMP:N-N(of)------------------------------+        
                           |        +---------------------------------------------------------SUBJ:V-N---------------------------------------------------------+                     |           +------------------------MOD_ATT:N-ADJ-----------------------+        
       +----MOD_ATT:N-N----+        |                                                    +---------------------OBJ:V-N--------------------+                    |                     |           |       +---------------------MOD_ATT:N-N--------------------+        
       |     +-MOD_ATT:N-N-+        +---------APPOS--------+----COMP:N-N(of)----+        +--------OBJ:V-N--------+                        +COMP:N-N(of+        +-------OBJ:V-N-------+           |       |                    +----------MOD_ATT:N-N----------+        
       |     |      +MOD_AT+        |           +MOD_ATT:N-+            +MOD_ATT+        |       +COMP:N-+       |               +MOD_ATT:+       +MOD+        |           +MOD_ATT:N+           |       |                    |              +---MOD_ATT:N-N--+        
       |     |      |      |        |           |          |            |       |        |       |       |       |               |        |       |   |        |           |         |           |       |                    |              |                |        
 In female adult __SP__ missing a ovary , subcutaneous injection of __NODE__ protein ( with a dosage of 200 mcg/kg/day and a treatment period of 17 days ) increases longitudinal growth of trabecular bone that involves 3 amino 1 hydroxypropylidene bisphosphonate .
MOD_ATT:N-N (miss,female)
MOD_ATT:N-N (miss,adult)
MOD_ATT:N-ADJ (miss,__SP__)
APPOS (ovary,injection)
MOD_ATT:N-ADJ (injection,subcutaneous)
COMP:N-N(of) (injection,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
OBJ:V-N (with,mcg/kg/day)
OBJ:V-N (with,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,day)
MOD_ATT:N-ADJ (day,@card@)
COMP:V-N(In) (increase,miss)
SUBJ:V-N (increase,ovary)
OBJ:V-N (increase,growth)
MOD_ATT:N-ADJ (growth,longitudinal)
COMP:N-N(of) (growth,bisphosphonate)
MOD_ATT:N-ADJ (bisphosphonate,trabecular)
MOD_ATT:N-N (bisphosphonate,bone)
MOD_ATT:N-N (bisphosphonate,amino)
MOD_ATT:N-N (bisphosphonate,hydroxypropylidene)